Tixagevimab

Definition: Tixagevimab/cilgavimab, sold under the brand name Evusheld, is a combination of two human monoclonal antibodies, tixagevimab (AZD8895) and cilgavimab (AZD1061) targeted against the surface spike protein of SARS-CoV-2 used to prevent COVID-19. It is being developed by British-Swedish multinational pharmaceutical and biotechnology company AstraZeneca. source: Wikipedia

ID

198551000202103

ID date

16 May 2024

Previous ID

40574011000001109

Name

Tixagevimab